These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7679878)

  • 1. Platelet activation in patients with thrombotic thrombocytopenic purpura.
    Hoffman M; Monroe DM; Roberts HR
    Am J Hematol; 1993 Feb; 42(2):182-5. PubMed ID: 7679878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.
    Valant PA; Jy W; Horstman LL; Mao WW; Ahn YS
    Br J Haematol; 1998 Jan; 100(1):24-32. PubMed ID: 9450786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.
    Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
    J Thromb Haemost; 2005 Nov; 3(11):2545-53. PubMed ID: 16241952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Galli M; Grassi A; Barbui T
    Thromb Haemost; 1996 Mar; 75(3):427-31. PubMed ID: 8701402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of platelet glycoproteins and platelet/endothelial cell antibodies in patients with thrombotic thrombocytopenic purpura.
    Wright JF; Wang H; Hornstein A; Hogarth M; Mody M; Garvey MB; Blanchette V; Rock G; Freedman J
    Br J Haematol; 1999 Dec; 107(3):546-55. PubMed ID: 10583256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
    van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.
    Jimenez JJ; Jy W; Mauro LM; Horstman LL; Ahn YS
    Br J Haematol; 2001 Jan; 112(1):81-90. PubMed ID: 11167788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelets-morphology, shape changing factor, and platelet agglutinating factor. TTP Research Group].
    Hattori A; Tatewaki W; Fuse I; Shibata A
    Nihon Rinsho; 1993 Jan; 51(1):122-8. PubMed ID: 8433504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased P-selectin plasma levels in patients with thrombotic thrombocytopenic purpura.
    Vianelli N; Catani L; Gugliotta L; Nocentini F; Baravelli S; Lancellotti G; Tura S
    Haematologica; 1996; 81(1):3-7. PubMed ID: 8900845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
    Katayama M; Handa M; Araki Y; Ambo H; Kawai Y; Watanabe K; Ikeda Y
    Br J Haematol; 1993 Aug; 84(4):702-10. PubMed ID: 7692937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Plasma Platelet Microparticles in Thrombotic Thrombocytopenic Purpura.
    Tahmasbi L; Karimi M; Kafiabadi SA; Nikougoftar M; Haghpanah S; Ranjbaran R; Moghadam M
    Ann Clin Lab Sci; 2017 Jan; 47(1):62-67. PubMed ID: 28249919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets.
    Lian EC; Siddiqui FA
    Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma P-selectin is increased in thrombotic consumptive platelet disorders.
    Chong BH; Murray B; Berndt MC; Dunlop LC; Brighton T; Chesterman CN
    Blood; 1994 Mar; 83(6):1535-41. PubMed ID: 7510145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Kelton JG
    Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura.
    Raife TJ; Atkinson B; Aster RH; McFarland JG; Gottschall JL
    Am J Hematol; 1999 Oct; 62(2):82-7. PubMed ID: 10509001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic thrombocytopenic purpura].
    Aul C; Scharf RE; Königshausen T; Schneider W
    Klin Wochenschr; 1985 Feb; 63(3):123-32. PubMed ID: 4038757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.